Why Should I Care About Cardiometabolic Disease?
Cardiometabolic Disease may be an unfamiliar term for you. In a nutshell, it is a new umbrella term used to define the risk relationship between cardiovascular disease (heart attack, atherosclerosis) and diabetes.
The progression of cardiometabolic disease often goes unnoticed for decades … just waiting until frank disease (such as heart attack, sudden cardiac death, stroke, diabetes) can be identified by traditional medicine only to be treated with a bevy of pharmaceuticals.
FoundationMED, by focusing on the root causes, and identifying (via advanced testing) known markers of early cardiometabolic disease, will work with you to interrupt the progression of disease and bring you back to a healthy foundation.
In 1988, Gerald Reaven, MD coined the term “Metabolic Syndrome” and wrote a book in the year 2000 “Syndrome X – Overcoming the Silent Killer That Can Give You A Heart Attack.” Dr. Reaven popularized the notion that a cluster of identifiable physiological changes (with insulin resistance as the primary driver) was behind the growing cardiovascular risk in individuals lacking traditional risk markers.
Since then, much research has been done (and is still being done) investigating the complex relationship between progressive insulin resistance and metabolic dysregulation and cardiovascular disease.
The most widely accepted description of this risk profile has been the term “Metabolic Syndrome“.
By utilizing advanced modern testing along with sound functional medicine principles, FoundationMED works with you to both identify and then reduce the risks associated with Metabolic Syndrome.